{"basic_info": {"ticker": "3681", "exchange": "XHKG", "bloomberg_ticker": "3681 HK Equity", "name": "SINOMAB BIOSCIENCE LTD", "industry": "Biotechnology", "name_chinese_simplified": "中国抗体", "period": "2020", "market_value": 4135648000, "total_income": 50000, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 45000, "business_income_over_total_income": 0.9}, {"shariah_compliance": "unknown", "income": 5000, "business_income_over_total_income": 0.1}], "details": [{"business_activity_cn": "从事研发医药产品", "business_activity_en": "Engaged in the research and development of pharmaceutical products", "income": 45000, "business_income_over_total_income": 0.9, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 5000, "business_income_over_total_income": 0.1, "shariah_compliance": "unknown"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": NaN, "shariah_compliance": "compliant", "amount_over_market_value": NaN}]}